Actively Recruiting
Hip Arthroscopy Postoperative Opioid Demands
Led by Rush University Medical Center · Updated on 2025-08-07
170
Participants Needed
1
Research Sites
331 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will be a prospective, single-blinded, randomized controlled trial (RCT), investigating the influence of the number of opioid pills prescribed following primary hip arthroscopy. All patients who sign the consent form will be enrolled in the suited and randomized to one of the two treatment arms. The intervention group will receive 5 Norco pills, gabapentin (30 mg, once daily for 10 days following surgery), and Tylenol (1000 mg, three times daily for 10 days following surgery) while the control will receive the standard at our practice of 30 Norco pills.
CONDITIONS
Official Title
Hip Arthroscopy Postoperative Opioid Demands
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients age 18-80 years
- English speaking
- Opioid naive patient (not taking opioid pills within 6 weeks prior to surgery), confirmed by prescription monitoring
- Undergoing primary hip arthroscopy
- Provided written and informed consent for study participation
You will not qualify if you...
- Under 18 years of age
- Opioid tolerant patients
- Revision hip surgery
- Prior infections of the operative joint
- History of active cancer within the past 5 years
- Chronic pain conditions including low back pain, chronic pain syndrome, fibromyalgia
- History of alcohol or substance use disorder
- Other diseases including rheumatologic conditions, diabetes, thyroid disorders, depression, anxiety
- Grade IV cartilage defects
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Rush University Medical Center
Chicago, Illinois, United States, 60612
Actively Recruiting
Research Team
C
Carla M. Edwards
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here